Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use
about
Current evaluation of alemtuzumab in multiple sclerosis.Novel drug therapies in myeloid leukemia.Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.
P2860
Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Alemtuzumab use in relapsed an ...... cussion of future rational use
@ast
Alemtuzumab use in relapsed an ...... cussion of future rational use
@en
type
label
Alemtuzumab use in relapsed an ...... cussion of future rational use
@ast
Alemtuzumab use in relapsed an ...... cussion of future rational use
@en
prefLabel
Alemtuzumab use in relapsed an ...... cussion of future rational use
@ast
Alemtuzumab use in relapsed an ...... cussion of future rational use
@en
P2860
P356
P1476
Alemtuzumab use in relapsed an ...... cussion of future rational use
@en
P2093
Jon E Arnason
P2860
P304
P356
10.1177/2040620712458949
P577
2012-12-01T00:00:00Z